Evidence map›Paper›PMID 37205371›Full record

ArticlebioRxiv : the preprint server for biology2023

TLR priming licenses NAIP inflammasome activation by immunoevasive ligands.

James P Grayczyk, Marisa S Egan, Luying Liu, Emily Aunins, Meghan A Wynosky-Dolfi, Scott Canna, Andy J Minn, Sunny Shin, Igor E Brodsky

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

James P GrayczykDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA, USA.
Marisa S EganDepartment of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Luying LiuDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA, USA.
Emily AuninsDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA, USA.
Meghan A Wynosky-DolfiDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA, USA.
Scott CannaDepartment of Pediatrics, Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA.
Andy J MinnDepartment of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Sunny ShinDepartment of Microbiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Igor E BrodskyDepartment of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA, USA.
University of Pennsylvania · USCancer Research Institute · USChildren's Hospital of Philadelphia · US

Funding

Innate immune-mediated control of pulmonary Legionella pneumophila infectionR01AI118861 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SHIN, SUNNY · 2016 to 2025
$4.6M
Defining the mechanism and functions of RIPK1-induced cell death in anti-bacterial immune defenseR01AI139102 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BRODSKY, IGOR E · 2019 to 2023
$2.8M
Defining human noncanonical inflammasome responses to Legionella pneumophilaR01AI123243 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SHIN, SUNNY · 2016 to 2020
$2.0M
Understanding Interleukin-18 Mediated Susceptibility to Systemic HyperinflammationR01HD098428 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CANNA, SCOTT WILLIAM · 2019 to 2023
$1.7M
Defining mechanisms of Casp1/11-independent death triggered by clinical Salmonella EnteritidisR21AI163596 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI BRODSKY, IGOR E · 2022 to 2023
$447k
TNF and caspase-8-mediated control of Legionella pneumophila infectionR21AI151476 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI SHIN, SUNNY · 2021 to 2022
$447k
A self-limited live RSV vaccine inducing anti- pre-fusion F antibodiesR21AI128520 · NIAID · OKLAHOMA STATE UNIVERSITY STILLWATER · PI OOMENS, ANTONIUS G · 2017 to 2018
$357k
Defining Mechanisms of NAIP5-independent Flagellin Sensing during Bacterial InfectionF32AI164655 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI GRAYCZYK, JAMES · 2021 to 2022
$100k
NIAID NIH HHS F32 AI164655NIAID NIH HHS R01 AI118861NIAID NIH HHS R01 AI123243NIAID NIH HHS R01 AI139102NIAID NIH HHS R21 AI128520NIAID NIH HHS R21 AI151476NIAID NIH HHS R21 AI163596NICHD NIH HHS R01 HD098428
6 · The paper itself

Abstract

NLR family, apoptosis inhibitory proteins (NAIPs) detect bacterial flagellin and structurally related components of bacterial type III secretion systems (T3SS), and recruit NLR family, CARD domain containing protein 4 (NLRC4) and caspase-1 into an inflammasome complex that induces pyroptosis. NAIP/NLRC4 inflammasome assembly is initiated by the binding of a single NAIP to its cognate ligand, but a subset of bacterial flagellins or T3SS structural proteins are thought to evade NAIP/NLRC4 inflammasome sensing by not binding to their cognate NAIPs. Unlike other inflammasome components such as NLRP3, AIM2, or some NAIPs, NLRC4 is constitutively present in resting macrophages, and not thought to be regulated by inflammatory signals. Here, we demonstrate that Toll-like receptor (TLR) stimulation upregulates NLRC4 transcription and protein expression in murine macrophages, which licenses NAIP detection of evasive ligands. TLR-induced NLRC4 upregulation and NAIP detection of evasive ligands required p38 MAPK signaling. In contrast, TLR priming in human macrophages did not upregulate NLRC4 expression, and human macrophages remained unable to detect NAIP-evasive ligands even following priming. Critically, ectopic expression of either murine or human NLRC4 was sufficient to induce pyroptosis in response to immunoevasive NAIP ligands, indicating that increased levels of NLRC4 enable the NAIP/NLRC4 inflammasome to detect these normally evasive ligands. Altogether, our data reveal that TLR priming tunes the threshold for NAIP/NLRC4 inflammasome activation and enables inflammasome responses against immunoevasive or suboptimal NAIP ligands.

Identifiers

PMID37205371
PMCPMC10187295
OpenAlexW4372319698

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.